Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 247 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NADOLOL | 80MG | TABLET | Resolved | 2023-12-08 | 2024-01-26 | 212919 |
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212922 |
| APO-TRAMADOL | 50MG | TABLET | Resolved | 2023-12-08 | 2023-12-22 | 212925 |
| APO-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212928 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212931 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-08 | 2024-02-23 | 212934 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212940 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-12-08 | 2024-01-05 | 212943 |
| APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-12-08 | 2024-03-22 | 212946 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-08 | 2024-01-12 | 212949 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-12-08 | 2024-01-05 | 212952 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212955 |
| APO-PERINDOPRIL | 8MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213550 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-15 | 2024-01-05 | 213553 |
| APO-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-12-15 | 2024-04-05 | 213556 |
| APO-GUANFACINE XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-15 | 2024-01-12 | 213559 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213562 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2023-12-15 | 2024-02-23 | 213565 |
| MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213568 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-DIPYRIDAMOLE | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-DIPYRIDAMOLE | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |